TidalSense
About:
TidalSense aims to create a paradigm shift in the practice of respiratory medicine, starting with earlier, accurate diagnosis.
Website: https://tidalsense.com
Twitter/X: tidalsense
Top Investors: Business Growth Fund, Foresight Group, SBRI Healthcare, Downing Ventures
Description:
Developer of AI-driven respiratory diagnostic and monitoring technologies. The company's technologies are built on a foundation of a novel sensor technology (N-Tidal) that is able to detect changes in lung function quickly and accurately. N-Tidal converts sensor data into (novel) respiratory biomarkers in near-real-time (minutes). Data is managed automatically and the device is 4G connected, handheld, portable and has high patient acceptability. Using these biomarkers, the company has built an affordable AI-driven diagnostic test for COPD which automates testing and interpretation in under 5 minutes (compared to the clinical standard 30 minutes).
10.3M GBP
$1M to $10M
Cambridge, Cambridgeshire, United Kingdom
2013-04-23
info(AT)tidalsense.com
11-50
2023-05-16
Private
© 2025 bioDAO.ai